“I think in the sensor area we still have more work to do. And I think it’s going to take a little longer in reducing the number of finger sticks, where we continue to make progress, but that’s going to be an area of pressure even going into next year” – these words come from Michael Coyle Executive Vice President Group President Medtronic Cardiac and Vascular Group – Mr. Coyle was taking question on the diabetes franchise as the new EVP for diabetes Mr. Salmon was not part of the earnings call.
Now we hate to be captain . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.